Form 4: INSMED Director Gifts 53,400 Shares to Family Trust
Insider Transaction Report
INSMED Director David W.J. McGirr reported gifting 53,400 shares of common stock to a family trust, effective February 9, 2026.
Summary
- Director David W.J. McGirr of INSMED Inc. reported a gift transaction of common stock.
- On February 9, 2026, McGirr disposed of 53,400 shares of common stock directly.
- Concurrently, a family trust indirectly acquired 53,400 shares of INSMED common stock, with a transaction price of $0 per share.
- Following these transactions, McGirr directly beneficially owns 44,323 shares, and the family trust indirectly beneficially owns 53,400 shares.
- The filing also includes a Limited Power of Attorney, dated August 6, 2025, appointing Michael A. Smith, Katrina S. Atieh, and Ian S. Macdonald as attorneys-in-fact for SEC reporting purposes.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. A director's gift of shares to a family trust is a personal financial decision and does not inherently reflect positively or negatively on the company's operational performance or future prospects.
Positives
- The transaction represents a planned transfer of ownership, potentially for estate planning purposes, which is a neutral event for the company's operational performance.
Negatives
- No direct negatives for the company's operational performance are indicated by this insider transaction.
Risks
- The Limited Power of Attorney explicitly states that neither the Company nor any attorney-in-fact assumes liability for the undersigned's responsibility to comply with Exchange Act or Securities Act requirements, or for any failure to comply, or for profit disgorgement under Section 16(b).
- The undersigned (David W.J. McGirr) remains responsible for compliance with obligations under the Exchange Act and Securities Act.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
StockSavvy.ai notes that insider transactions, such as gifts, are common and often relate to personal financial planning or estate management rather than reflecting a direct change in the company's operational performance or strategic outlook. This transaction is typical for a director's personal asset management.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Delegation of Authority | David W.J. McGirr granted a Limited Power of Attorney to Michael A. Smith, Katrina S. Atieh, and Ian S. Macdonald to handle SEC reporting obligations (Forms 3, 4, 5, and 144) on his behalf. | August 6, 2025 | This streamlines the director's compliance with SEC filing requirements by delegating administrative tasks to designated attorneys-in-fact, ensuring timely and accurate reporting of insider transactions. |
Related Party Transactions
- Director David W.J. McGirr gifted 53,400 shares of INSMED Inc. common stock to a family trust, which is considered a related party transaction due to the familial relationship and indirect beneficial ownership.
Stakeholder Impact
- Shareholders: The transaction represents a transfer of ownership within a related party and does not directly impact the company's operational performance or financial health. It may slightly increase the indirect ownership stake of a family trust associated with a director.
- Employees, Customers, Suppliers, Creditors: No direct impact is expected on these stakeholders as the transaction is a personal financial matter for a director.
Key Dates
| Date | Description |
|---|---|
| August 6, 2025 | Date of execution of the Limited Power of Attorney by David W.J. McGirr. |
| February 9, 2026 | Date of the reported gift transaction of common stock. |
| February 11, 2026 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThis Form 4 filing reports a director's gift of shares to a family trust, which is a personal financial planning event and not indicative of the company's operational performance or future prospects. As such, it provides no new information that would warrant a change in investment recommendation for INSMED Inc. The stock should be held based on existing fundamental analysis.
Keywords
INSMED Inc, INSM, Form 4, Insider Transaction, Stock Gift, Director, Beneficial Ownership, Family Trust, SEC Filing, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.